First Video Conference of New Project Year for the OHSU/BDMS Collaboration Jan 16, 2018 Global Office at OHSU in Portland and BDMS Locations in Thailand.

Slides:



Advertisements
Similar presentations
Lipid Management in 2015: Risk & Controversies
Advertisements

U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
The Healthy Heart Figure 14.1.
CVD risk estimation and prevention: An overview of SIGN 97.
Lipids 101 Cardiology Board Review Med-Peds Style!
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Obesity Treatment in Special Populations
Brooke Nessen Health Class (Grades 10-12) Explaining Cholesterol (Video)
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
When blood vessels, such as arteries, get blocked by lipids (LDL), it is hard for blood to move through the blood vessels. If an artery in the heart gets.
Risk Factors for Premature Atherosclerotic Heart Disease Dyslipidemia (high LDL, low HDL) Diabetes Hypertension Obesity Sedentary lifestyle Obesity Smoking.
Cardiovascular Disease in Women Module VII: Evidence-Based Guidelines.
Department of Medicine Grand Rounds Clinical Vignette April 15, 2009 Michael Owen, PGY 2.
Check the Lipid Profile? Why? Douglas W. Teske, MD The Heart Center Nationwide Children’s Hospital Douglas W. Teske, MD The Heart Center Nationwide Children’s.
Department of Family & Community Medicine
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
Management of Obesity and Dyslipidemia Presented by : Faisal Hassan Hussain.
Adi Kartolo University of Ottawa. Initial Presentation 42-year-old African-American male with type 2 diabetes Chief Complaint: increasing body weight.
Nutrition & Heart Disease Key Concepts and Facts Heart disease is leading cause of death Dietary and lifestyle factors are important Diets that provide.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
Tina Huang.  Aimed at people aged 40 – 74  Risk assessment and management programme to prevent or delay the onset of diabetes, heart and kidney disease.
Hypertension, Cardiovascular Disease, Diabetes. 34% of Americans 36% of Americans.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Clinical Correlations The NYU Langone Online Journal of Medicine
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Prince Sattam Bin AbdulAziz University College Of Pharmacy Professor Mohammad Abd- elmotaal Mohammad Ruhal Ain, R Ph, PGDPRA, M Pharm Diabetes Mellitus.
Case I A 47 old male presents to your office for a yearly checkup. He smokes 40 cigarette/day, and examination detect wheezy chest and bronchospasm. His.
Better Health. No Hassles. HIGH BLOOD CHOLESTEROL Cholesterol is found in every cell in our body. Cholesterol is used to build healthy cells, as well as.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
Coronary Heart Disease in Women Dr.AHMAD ALAYED د.أحمد العايد إستشاري أمراض القلب و القثطرة القلبية مركز الباسل لأمراض و جراحة القلب بدمشق.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Cholesterol, blood pressure, and heart disease
FOURIER Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Redefining Quality Care in T2DM Patients with CV Disease
The Plasma Concentrations of Atorvastatin and its Active Metabolites in Relation to the Dose in Stable Coronary Artery Disease Patients at a Tertiary Referral.
Mini-Lecture Michelle Di Fiore Revised 4/2017
Diabetes, Dyslipidemia, and Continuous Quality Improvement Using the Chronic Care Model in the Treatment of Patients Class of 2011, Family and Community.
Dyslipidemia and Primary Prevention
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Cholesterol practice questions
Diabetes Health Status Report
Heart Health & Diabetes
by:Graham Holmes, Jacob Peters, and Kassie Shepherd
Neil J. Stone et al. JACC 2014;63:
Patients aged 85yrs and over
Lipid Treatment Updates in Management
Developing a Heart-Healthy Life Style
Cholesterol, blood pressure, and heart disease
Fort Atkinson School District Wellness Program
Rational Order of Laboratory Tests in Cardiovascular Diseases
Latest Lipid Guidelines in Perspective
Coding from The bottom up
Patient Examples of CMR Stress Test in Women Patient #1 is a 70-year-old, post-menopausal woman with typical angina and 3 coronary artery disease (CAD)
Goals & Guidelines A summary of international guidelines for CHD
Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention-
Train-the-Trainer Cases
Pandemic Lipid Edition
Preventative Cardiology
Train-the-Trainer Cases
Train-the-Trainer Cases
Putting Your Skills to the Test
Insert Case Title Case Overview
Dyslipidemia And Diabetes
Case—History 75 year old woman referred for statin intolerance in 2016
Nutrition and Food Sciences
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

First Video Conference of New Project Year for the OHSU/BDMS Collaboration Jan 16, 2018 Global Office at OHSU in Portland and BDMS Locations in Thailand

Agenda Welcome and Introductions Discussion about format of the newly approved project for 2018 Discussion about format and scope of the monthly video conferences Recent case managed at the Center for Preventive Cardiology Case from BDMS? Other issues and conclusions

Case 54 yo female, of Asian Indian ethnicity but on western diet and lifestyle, referred by PCP for CVD risk evaluation in the context of progressively increasing LDL levels over time, seen in clinic on January 9, 2018. History of severe inflammatory bowel disease with colic resection and placement of stoma (9 years prior). History of chronic obesity with bariatric surgery (6 years prior) leading to weight loss (40 lbs) followed by weight gain (60 lbs) No known or suspected CAD, no diabetes or dysglycemia, three normal pregnancies without GD.

Case She also has history of: • LFT elevations and fatty liver • Depression   • GERD   • Gout       • Hypertension   • Migraine     • Severe anxiety   • Sleep apnea What is her dyslipidemia?  

Medications Metoprolol and amlodipine for HTN Anti-TNF alpha and Methotrexate for RA Lexapro (escitalopram) for depression High dose vitamin B complex and folic acid, and 50,000 IU of vitamin D with calcium carbonate supplementation No lipid modulators. Reports prior exposure to atorvastatin with development of severe leg pain and generalized fatigue after a few weeks on therapy. Absolutely unwilling to try another statin.

Findings BP 141/86 Pulse 107 Ht 1.588 m (5' 2.5") Wt 103.6 kg (228 lb 6.4 oz) SpO2 97% BMI 41.11 kg/(m^2) 

Lipid Panel

Lipid Panel

Other Labs

Chest CT w/o Contrast EXAM: CT CORONARY ARTERY CALCIUM SCORE 01/10/18 10:32:53 FINDINGS: The coronary arteries arise in normal position and have a normal course. There is moderate coronary artery calcification, resulting in an Agatston score 147 (38 in the left main, 2 in the LAD, 12 in the LCx, and 95 in the RCA). The right and left ventricular chambers are of normal position in size. Aortic valvular calcifications noted. There is also minimal mitral annular calcification. IMPRESSION: Moderate evidence of coronary artery calcification resulting in an Agatston score = 147. This corresponds to the 96th percentile for age and gender.

Impressions and Plan Chronically obese patient affected by a severe form of dyslipidemia, characterized by LDL levels recently above 200 mg/dl (today's value 231) and mildly elevated triglycerides with normal HDL and borderline Lp(a) levels. She has intolerance to statins with severe myalgia on atorvastatin. She is unwilling to try statins again. Her LDL is in the range of FH. CT of the chest for coronary calcium scoring showed multiple calcified plaques, mostly in the RCA but also including left main, LAD, and LCx. It may be appropriate to perform a stress echo if the patient discloses any symptoms upon additional questioning. Her LDL target is <70 mg/dl, a very long distance from the current value. Considering her unwillingness to try another statin, I recommend starting ezetimibe 10 mg and initiate paperwork for PCSK9 inhibitor. In addition, today the patient saw our dietitian as part of the first visit package. Dietitian’s notes are produced separately. She has elevated blood pressure in office, and thus agrees to monitor values for a week at home and report back to us for medication adjustment if needed.

Discussion Points What would have been done differently in your hospital? What else does this patient need for maximum CVD risk control? ASA? TG management beyond fish oil supplements? Does HbA1c of 5.9% require action?

Agenda Welcome and Introductions Discussion about format of the newly approved project for 2018 Discussion about format and scope of the monthly video conferences Recent case managed at the Center for Preventive Cardiology Case from BDMS? Other issues and conclusions

Agenda Welcome and Introductions Discussion about format of the newly approved project for 2018 Discussion about format and scope of the monthly video conferences Recent case managed at the Center for Preventive Cardiology Case from BDMS? Other issues and conclusions